The ROSA Shoulder robotic application has received positive feedback, indicating strong potential for long-term growth in the robotics-assisted surgery segment. Additionally, Zimmer Biomet has ...

Gross margins are projected to range from 47% to 51%, benefiting from improved transfer pricing under the Zimmer Biomet partnership. Rosa stated that the company is on track to submit a 510(k ...

Zimmer Biomet (NYSE: ZBH) announced today that it received FDA 510(k) clearance for its Persona Revision SoluTion Femur.

SINGAPORE, March 30, 2023 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that ROSA HIP ® with ONE Plannerâ„¢ Hip won the ...

WARSAW, Ind., Feb. 25, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced upcoming changes to the Company's Board of ...

WARSAW, Ind., March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cooper Co (COO – Research Report) and Zimmer Biomet Holdings ...

Zimmer Biomet's product pipeline remains a key strength, with several innovative offerings poised to drive future growth. The ROSA Shoulder robotic application has received positive feedback ...